Last ¥3,658 JPY
Change Today -66.00 / -1.77%
Volume 2.0M
4578 On Other Exchanges
Symbol
Exchange
Tokyo
Berlin
OTC US
OTC US
As of 1:00 AM 01/30/15 All times are local (Market data is delayed by at least 15 minutes).

otsuka holdings co ltd (4578) Snapshot

Open
¥3,731
Previous Close
¥3,724
Day High
¥3,759
Day Low
¥3,655
52 Week High
11/6/14 - ¥4,019
52 Week Low
04/9/14 - ¥2,773
Market Cap
2.0T
Average Volume 10 Days
1.2M
EPS TTM
¥301.74
Shares Outstanding
557.8M
EX-Date
12/26/14
P/E TM
12.1x
Dividend
¥75.00
Dividend Yield
2.05%
Current Stock Chart for OTSUKA HOLDINGS CO LTD (4578)

Related News

No related news articles were found.

otsuka holdings co ltd (4578) Related Businessweek News

View More BusinessWeek News

otsuka holdings co ltd (4578) Details

Otsuka Holdings Co., Ltd manufactures and sells healthcare products worldwide. The company operates in four segments: Pharmaceuticals, Nutraceuticals, Consumer Products, and Other. The Pharmaceuticals segment is involved in the research and development, production, and sale of therapeutic drugs in the areas of central nervous system, oncology, cardiovascular system, gastroenterology, respiratory system, infectious disease, ophthalmology, dermatology, allergies, urology, and others; intravenous and enteral nutrition solutions; influenza diagnostic agents, Helicobacter pylori test kits, and other products; and apheresis device for leukocyte adsorption, drug-eluting stents, and other products, as well as provides contract manufacturing services. The Nutraceuticals segment provides functional foods and beverages, such as electrolyte supplement drinks, carbonated nutritional drinks, soy soda beverages, soy snacks, and OTC and quasi-drugs. The Consumer Products segment offers alcoholic beverages; foods; and beverages, such as mineral water, carbonated vitamin drink, and straight tea, as well as curries in retort pouches, curries paste, and curry powder. The Other segment provides functional and fine chemicals for the automotive, electrical, electronic, and building materials sectors; and transport and warehousing services for pharmaceuticals, foods, and beverages. This segment also develops, manufactures, and markets optical evaluation/inspection equipment, liquid crystal display panel materials, and finished products, as well as medical equipment and clinical diagnostic equipment. The company was founded in 1921 and is headquartered in Tokyo, Japan.

28,288 Employees
Last Reported Date: 06/30/14
Founded in 1921

otsuka holdings co ltd (4578) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

otsuka holdings co ltd (4578) Key Developments

Otsuka Australia Pharmaceutical Pty Ltd Opens New Office in Sydney

Otsuka Pharmaceutical Co. Ltd. established a direct presence in Australia. A new office has been opened in Sydney to bring innovative new medicines to patients in Australia and as a foundation on which to build a larger, long-term presence in Australia and elsewhere in Oceania. Otsuka is committed to the development of innovative new drugs for central nervous system disorders such as schizophrenia, depression and Alzheimer's disease, areas where patients in Australia and elsewhere await better treatments. There are an estimated 285,000 people in Australia with schizophrenia, one million with depression and 298,000 with dementia, a significant number of whom have dementia of the Alzheimer's type. The Australian drug market has experienced single-digit percentage growth in the past several years and was estimated at approximately $13 billion (JPY 1.1 trillion or USD 13.6 billion) in 2012, placing it 12th in size in the world.

Otsuka Holdings Co., Ltd. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 02:00 PM

Otsuka Holdings Co., Ltd. Presents at 33rd Annual J.P. Morgan Healthcare Conference, Jan-13-2015 02:00 PM. Venue: Westin St. Francis Hotel, San Francisco, California, United States. Speakers: Tatsuo Higuchi, Chief Executive Officer, President, Representative Director and Chairman of Risk Management Committee.

Otsuka Holdings Company Limited Reports Earnings Results for the Six Months Ended September 2014; Provides Earnings Guidance for the Fiscal Year Ending December 31, 2014

Otsuka Holdings Company Limited has reported that net income for the first six months ended September 30, 2014 was JPY 99.50 billion, or JPY 183.64 per diluted share, compared to JPY 87.02 billion, or JPY 159.45 per diluted share, for the same period ended September 30, 2013. Net sales for the first six months ended September 30, 2014 were JPY 788.28 billion, compared to JPY 699.41 billion for the same period ended September 30, 2013. Operating income for the first six months ended September 30, 2014 was JPY 136.65 billion, compared to JPY 111.72 billion for the same period ended September 30, 2013. Ordinary income for the first six months ended September 30, 2014 was JPY 148.12 billion, compared to JPY 121.99 billion for the same period ended September 30, 2013. For fiscal year ending December 31, 2014, the company expects net income of JPY 130 billion, or JPY 240 per basic share, and net sales of JPY 1.20 trillion.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4578:JP ¥3,657.50 JPY -66.00

4578 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4578.
View Industry Companies
 

Industry Analysis

4578

Industry Average

Valuation 4578 Industry Range
Price/Earnings 11.5x
Price/Sales 1.2x
Price/Book 1.2x
Price/Cash Flow 10.5x
TEV/Sales 0.8x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OTSUKA HOLDINGS CO LTD, please visit www.otsuka.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.